Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Efficacy, safety, biomarker, and pharmacokinetic results from Checkmate 908 Meeting Abstract
| Authors: | Dunkel, I. J.; Cohen, K.; Foreman, N. K.; Hargrave, D.; Lassaletta, A.; André, N.; Hansford, J. R.; Hassall, T.; Eyrich, M.; Gururangan, S.; Bartels, U.; Gajjar, A.; Howell, L.; Warad, D.; Pacius, M.; Tam, R.; Wang, Y.; Zhu, L.; Doz, F. |
| Abstract Title: | Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Efficacy, safety, biomarker, and pharmacokinetic results from Checkmate 908 |
| Meeting Title: | 20th International Symposium on Pediatric Neuro-Oncology (ISPNO 2022) |
| Journal Title: | Neuro-Oncology |
| Volume: | 24 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Jun 12-15 |
| Meeting Location: | Hamburg, Germany |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-06-01 |
| Start Page: | i82 |
| End Page: | i83 |
| Language: | English |
| ACCESSION: | WOS:000840122400304 |
| PROVIDER: | wos |
| DOI: | 10.1093/neuonc/noac079.301 |
| Notes: | Meeting Abstract: IMMU-08 -- Source: Wos |
